Performance Health is a medical and physical therapy supply manufacturing company head-quartered in Illinois, United States. The company is a merge of two companies: Performance Health Inc, which originated in Export, Pennsylvania and Hygenic Corporation which originated in Akron, Ohio. They manufacture and deliver pro…
An institutional-grade, numbers-driven thesis on BDMD — generated on demand from live fundamentals, scores and forecast.
Member feature · 7-day free trial · no charge today · cancel anytime
As of July 4, 2026, TradersQuant's model rates Baird Medical Investment Holdings Ltd (BDMD) 51/100 with a 12-month base-case forecast of $0.99 — -16.1% versus the current price of $1.18. Baird Medical Investment Holdings Ltd trades at $1.18 in the Health Care sector, with a market capitalisation of $48.4M. The score blends valuation, growth, earnings quality and momentum into a single grade.
The 12-month TradersQuant model price target for BDMD is $0.99, implying -16.1% versus the current price. The model's 12-month scenario range runs from $0.90 (bear) to $1.11 (bull), with a base case of $0.99.
On the fundamentals, Baird Medical Investment Holdings shows trailing revenue of $22.5M. This page also tracks BDMD's short interest, institutional (smart-money) positioning and the options market — the same cross-signal view institutions watch.
BDMD currently carries a TradersQuant composite score of 51/100, which we read as a neutral-to-watch signal. Our 12-month price target of $0.99 implies -16.1% from $1.18. This is research, not financial advice — always combine it with your own judgement.
The TradersQuant 12-month model price target for BDMD is $0.99, about -16.1% versus the latest price of $1.18.
TradersQuant's 12-month model forecast for BDMD is a base case of $0.99, ranging from $0.90 (bear) to $1.11 (bull), an expected return of -16.3%. Forecasts are model estimates, not guarantees.
The TradersQuant price prediction for BDMD over the next 12 months is $0.99 in the base case (bear $0.90, bull $1.11), versus today's price of $1.18. Unlike black-box prediction sites, every TradersQuant call is logged at the price and date it was made and graded publicly against the S&P 500.
We deliberately don't publish 2030 price predictions for BDMD — no model can honestly forecast a single stock five-plus years out, and sites that do are guessing. TradersQuant focuses on a rigorous 12-month bull/base/bear range, refreshed continuously and graded on our public track record.
TradersQuant estimates BDMD's fair value at $1.48, implying +25.5% of expected upside versus the current price.
Baird Medical Investment Holdings does not currently pay a dividend.
Data and model outputs are for research only and are not financial advice. Figures update continuously.
